The phrase "already the target" is correct and usable in written English.
It can be used to indicate that something or someone has been identified or designated as a target prior to the current moment.
Example: "The new policy has made our organization already the target of criticism from various stakeholders."
Alternatives: "already identified as the target" or "previously designated as the target".
At the time, Merck was already the target of Vioxx-related plaintiffs' lawsuits.
Normandy was already the target of a takeover offer from AngloGold, which Newmont said it outbid by about 21percentt.
Instead, we will be asked to authorise strikes against Isis, already the target of RAF bombing missions in Iraq.
Under new boss Antony Jenkins, Barclays is thought likely to remove managing directors from the investment bank, already the target of more than 1,600 reductions a year ago, when it publishes its results next month.
Morgan Stanley, already the target of a government sex-bias suit rooted in a 1998 claim by a fired bond trader, was discriminating against women in 2003 and might be sued again, the Equal Employment Opportunity Commission said yesterday.
Already the target of four major wins that stands between him and Nicklaus is looking more demanding with every passing year; if he does not hurry up, he may find himself swept away by an incoming tide.
Muslim communities are already the targets of counter-radicalization policing.
Aspartic proteases are already the targets of some clinically useful drugs (e.g. chemotherapy of HIV infection) and a variety of factors make these enzymes appealing to those seeking novel antiparasite therapies.
The pathway components here described are already the targets of therapeutic interventions with pharmacologic or biotechnologic inhibitors in other types of epithelial tumors [21].
Fortunately, many of the signaling pathways are already the targets of current FDA-approved therapeutic drugs such as bevacizumab (Avastin) against VEGF, ramucirumab (Cyramza) against VEGF receptor, cetuximab (Erbitux) and panitumumab (Vectibix) against EGF receptor.
Iran has already been the target of two sets of economic sanctions.
